Curapath Honored By PaternaMajor and Spanish Government Innovation Delegation

PaternaMajor and the Spanish Government Innovation Delegation identified Curapath (formerly PTS), as one of the most innovative companies in the Valencian Community region. The Government delegate in the Valencian Community, Pilar Bernabe, visited the Paterna Technology Park, an area that has a number of high-tech industries, research centers and significant focus on innovative research and development. They performed a site visit on Monday October 3, to learn more about our work, history and growth plans. They were interested in our participation in the mRNA vaccine field, particularly in relation to our collaboration with HIPRA (Hipra Laboratories, S.A.).

Read press coverage of the visit to Curapath

The Latest from Curapath
ABITEC and Curapath Sign Strategic Memorandum of Understanding (MOU) to Advance Next-Generation LNP Delivery Technologies

ABITEC Corporation and Curapath have signed a strategic MOU to expand access to high-purity custom lipids, PEG-free shielding technologies, and advanced lipid nanoparticle (LNP) formulation solutions....

Curapath Joins the ARTHEx-Led Consortium for the NEUROAN Project to Advance Next-Generation RNA Therapeutics for Neuromuscular Diseases

Curapath is participating in the NEUROAN project, a strategic collaborative initiative led by ARTHEx Biotech that brings together ARTHEx Biotech, ProtoQSAR, AMS Biopharma and Curapath, to...

Macro Biologics and Curapath Enhance Their Strategic Collaboration to Advance Amicidin‑α Surgical Gel Toward Clinical Evaluation

Curapath is pleased to acknowledge the significant progress achieved by Macro Biologics, Inc., whose IND application for Amicidin‑α Surgical Gel has been accepted by the FDA,...